menu
    • menu

    Company profile for APOPHARMA

    NEW Drugs in Dev: 2
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ApoPharma Inc. is an innovative drug company devoted to providing drug products that help improve the quality of life of patients with debilitating and life-threatening diseases.We may be a small pharmaceutical company but we use this as an advantage. The team we have assembled is very much attuned to the needs of our customers and aligned with the ApoPharma vision and mission.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    APOPHARMACanada Flag
    Country
    Country
    Canada
    Address
    Address
    ApoPharma Inc. 200 Barmac Drive Toronto, Ontario, Canada, M9L 2Z7
    Telephone
    Telephone
    1.800.268.4623/1.416.749.9300
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.apopharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Apopharma`s Generics Rivaroxaban Receives Tentative Approval in US
    Apopharma`s Generics Rivaroxaban Receives Tentative Approval in US

    15 Oct 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217810

    FDA
    15 Oct 2024
    Share Share
    Apopharma's Generic Apremilast Receives Approval in the U.S.
    Apopharma's Generic Apremilast Receives Approval in the U.S.

    24 Jan 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217258

    FDA
    24 Jan 2024
    Share Share
    Patent Challenges for ApoPharma’s Ferriprox and Akorn’s Zioptan
    Patent Challenges for ApoPharma’s Ferriprox and Akorn’s Zioptan

    30 Mar 2016

    // TWOFOUR INSIGHT

    http://twofourinsight.com/patent-challenges-apopharma-ferriprox-akorn-zioptan/

    TWOFOUR INSIGHT
    30 Mar 2016
    Share Share
    Apotex Announces FDA Has Accepted For Filing its Biosimilar Application for Filgrastim (Grastofil™)
    Apotex Announces FDA Has Accepted For Filing its Biosimilar Application for Filgrastim (Grastofil™)

    17 Feb 2015

    // Press Release APOTEX

    http://www.apotex.com/global/about/press/20150217-2.asp

    Press Release APOTEX
    17 Feb 2015
    Share Share
    ApoPharma Announces Health Canada Approval of Ferriprox (deferiprone)
    ApoPharma Announces Health Canada Approval of Ferriprox (deferiprone)

    17 Feb 2015

    // Press Release APOTEX

    http://www.apotex.com/global/about/press/20150217-1.asp

    Press Release APOTEX
    17 Feb 2015
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search